Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals in the United States, Europe, the Asia Pacific, Mexico, Canada, and internationally. It operates in two segments, Specialty Alloys Operations and Performance Engineered Products. The company offers specialty alloys, including titanium alloys, powder metals, stainless steels, alloy steels, and tool steels, as well as additives, and metal powders and parts. It serves to aerospace, defense, medical, transportation, energy, industrial, and consumer markets. The company was founded in 1889 and is headquartered in Philadelphia, Pennsylvania.

Carpenter Technology Corporation

Crispr Therapeutics AG ( ($CRSP) ) has fallen by -9.20%. Read on to learn why. Crispr Therapeutics AG has experienced a notable decline in its stoc...

Crispr Therapeutics AG Faces Stock Price Slide

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 20, as revealed in daily fun...

Cathie Wood Buys Nvidia, ACHR and Crypto Stocks, Offloads AMD, EXAS

The latest announcement is out from Carpenter Technology ( ($CRS) ). On November 20, 2025, Carpenter Technology Corporation completed a $700 millio...

Carpenter Technology Completes $700 Million Senior Notes Offering

In a report released yesterday, from Berenberg Bank reiterated a Hold rating on Crest Nicholson Holdings, with a price target of p180.00. The compa...

Crest Nicholson Holdings (CRST) Gets a Hold from Berenberg Bank

In a report released today, Rajesh Patki from Barclays maintained a Hold rating on Crest Nicholson Holdings, with a price target of £2.10. Accordin...

Barclays Remains a Hold on Crest Nicholson Holdings (CRST)

In a report released today, from Peel Hunt reiterated a Buy rating on Crest Nicholson Holdings, with a price target of p190.00. The word on The Str...

Peel Hunt Sticks to Its Buy Rating for Crest Nicholson Holdings (CRST)

Crispr Therapeutics ( ($CRSP) ) has released its Q3 earnings. Here is a breakdown of the information Crispr Therapeutics presented to its investors...

CRISPR Therapeutics Reports Q3 2025 Financial Results

In a report released today, from Oppenheimer maintained a Buy rating on Crispr Therapeutics AG, with a price target of $95.00. In addition to Oppen...

Oppenheimer Sticks to Their Buy Rating for Crispr Therapeutics AG (CRSP)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Perspective Therapeutics (CATX – Research Report), C...

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), Crispr Therapeutics AG (CRSP) and Upstream Bio, Inc. (UPB)

Barclays analyst Gena Wang maintained a Hold rating on Crispr Therapeutics AG today and set a price target of $56.00. According to TipRanks, Wang i...

Barclays Remains a Hold on Crispr Therapeutics AG (CRSP)

Looking for top-rated stocks to buy now? Based on recent analyst updates, the three companies below have all earned Strong Buy ratings from Top Wal...

3 Best Stocks to Buy Now, 11/10/2025, According to Top Analysts

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported several trades for Tuesday, November 4, 2025, highlighting new buys in biotech stock...

CRSP, BEAM, ROKU, SOFI: Cathie Wood Pours $17 Million into Biotech Stocks, Trims Tech Favorites

Crest Nicholson Holdings ( ($GB:CRST) ) has provided an update. Crest Nicholson Holdings PLC announced its total voting rights as of 31 October 202...

Crest Nicholson Announces Total Voting Rights Update

In a report released today, Alicia Reese from Wedbush maintained a Buy rating on Corsair Gaming, with a price target of $13.00. The company’s share...

Wedbush Reaffirms Their Buy Rating on Corsair Gaming (CRSR)

In a report released today, Anthony Stoss from Craig-Hallum maintained a Buy rating on Corsair Gaming. The company’s shares opened today at $8.35. ...

Corsair Gaming (CRSR) Gets a Buy from Craig-Hallum

Crispr Therapeutics AG ( ($CRSP) ) has fallen by -8.60%. Read on to learn why. Crispr Therapeutics AG has experienced a notable decline in its stoc...

Crispr Therapeutics AG Faces Stock Price Slump

There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Carpenter Technology (CRS – Research Report) a...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CRS	$309.42	+1.32%	854.68K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CRS	$309.42	+1.3%	854.68K
3
4
5
6

CRS

CRS

Get Carpenter Technology Corporation Data in Excel

Get Carpenter Technology Corporation Data in Excel